Synthesis, Characterization and Biological Evaluation of Benzothiazole–Isoquinoline Derivative
作者:Weihua Liu、Donghai Zhao、Zhiwen He、Yiming Hu、Yuxia Zhu、Lingjian Zhang、Lianhai Jin、Liping Guan、Sihong Wang
DOI:10.3390/molecules27249062
日期:——
Currently, no suitable clinical drugs are available for patients with neurodegenerative diseases complicated by depression. Based on a fusion technique to create effective multi-target-directed ligands (MTDLs), we synthesized a series of (R)-N-(benzo[d]thiazol-2-yl)-2-(1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl) acetamides with substituted benzothiazoles and (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
目前,尚无适用于神经退行性疾病并发抑郁症患者的临床药物。基于创建有效的多目标定向配体 (MTDL) 的融合技术,我们合成了一系列 (R)-N-(benzo[d]thiazol-2-yl)-2-(1-phenyl-3, 4-dihydroisoquinolin-2(1H)-yl) acetamides with substituted benzothiazoles and (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline. 通过体外酶活性测定测试所有化合物对单胺氧化酶 (MAO) 和胆碱酯酶 (ChE) 的抑制效力,并进一步测试其对单胺氧化酶 B (MAO-B) 和丁酰胆碱酯酶 (BuChE) 的特异性抑制效力。其中,6 种化合物(4b-4d、4f、4g 和 4i)表现出优异的活性。经典的抗抑郁药强迫游泳试验(FST)用于验证体外结果,表明六种化合物显着缩短了固定时间,尤其是化合物